To explore the role of 2-hydroxyglutarate (2HG) in cancer metabolism, its impact on tumor heterogeneity, and its potential as a therapeutic target, emphasizing its significance in cancer biology.
Key Findings:
2HG disrupts epigenetic regulation and redox balance, contributing to tumor initiation and progression, with implications for therapy resistance.
The enantiomers of 2HG play a significant role in therapy resistance and tumor heterogeneity, highlighting the need for targeted approaches.
2HG can serve as a biomarker and therapeutic target in cancer treatment, offering new strategies for intervention.
Interpretation:
The findings underscore the importance of understanding 2HG's role in cancer biology, which could lead to improved diagnostic and therapeutic strategies, particularly in targeting therapy resistance.
Limitations:
The review may not cover all aspects of 2HG's role in cancer due to the complexity of metabolic pathways and potential biases in the literature.
Further research is needed to fully elucidate the mechanisms by which 2HG influences cancer progression and to address existing gaps in knowledge.
Conclusion:
2HG is a critical oncometabolite that influences cancer pathways and presents opportunities for targeted therapies, underscoring the urgency of addressing its role in cancer treatment.
